iRhythm Technologies Past Earnings Performance
Past criteria checks 0/6
iRhythm Technologies's earnings have been declining at an average annual rate of -20.7%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 20.3% per year.
Key information
-20.7%
Earnings growth rate
-17.2%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 20.3% |
Return on equity | -209.9% |
Net Margin | -26.9% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
iRhythm Technologies: Today's 510(K) Victory May Only Be A Temporary Reprieve
Oct 22Take Care Before Jumping Onto iRhythm Technologies, Inc. (NASDAQ:IRTC) Even Though It's 26% Cheaper
Oct 13Is iRhythm Technologies (NASDAQ:IRTC) A Risky Investment?
Sep 19Getting In Cheap On iRhythm Technologies, Inc. (NASDAQ:IRTC) Might Be Difficult
Jul 13iRhythm Technologies (NASDAQ:IRTC) Is Carrying A Fair Bit Of Debt
May 13iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't
Mar 25Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results
Feb 25iRhythm Technologies (NASDAQ:IRTC) Has Debt But No Earnings; Should You Worry?
Feb 02iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 30% Below Their Intrinsic Value Estimate
Dec 20iRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable
Dec 20Is Now An Opportune Moment To Examine iRhythm Technologies, Inc. (NASDAQ:IRTC)?
Dec 02Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?
Sep 20iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 25% Below Their Intrinsic Value Estimate
Aug 30When Should You Buy iRhythm Technologies, Inc. (NASDAQ:IRTC)?
Jul 04Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?
Jun 16Estimating The Intrinsic Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)
May 26iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S Is On The Mark
May 08What Does iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Indicate?
Mar 27Is iRhythm Technologies (NASDAQ:IRTC) Using Debt Sensibly?
Feb 25Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?
Nov 24iRhythm falls after reaffirming 2022 guidance
Sep 21iRhythm: Fairly Priced At Current Multiples, No Need To Size Up
Sep 02Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?
Aug 18iRhythm Technologies Q2 results beat estimates, co raises FY 2022 revenue guidance
Aug 04Revenue & Expenses Breakdown
How iRhythm Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 560 | -151 | 408 | 68 |
30 Jun 24 | 537 | -132 | 393 | 68 |
31 Mar 24 | 513 | -130 | 378 | 62 |
31 Dec 23 | 493 | -123 | 370 | 60 |
30 Sep 23 | 473 | -105 | 356 | 58 |
30 Jun 23 | 452 | -99 | 354 | 53 |
31 Mar 23 | 430 | -105 | 344 | 51 |
31 Dec 22 | 411 | -116 | 317 | 47 |
30 Sep 22 | 380 | -128 | 304 | 46 |
30 Jun 22 | 362 | -131 | 297 | 43 |
31 Mar 22 | 341 | -124 | 278 | 41 |
31 Dec 21 | 323 | -101 | 275 | 39 |
30 Sep 21 | 320 | -79 | 260 | 38 |
30 Jun 21 | 306 | -59 | 238 | 38 |
31 Mar 21 | 276 | -63 | 219 | 41 |
31 Dec 20 | 265 | -44 | 197 | 41 |
30 Sep 20 | 245 | -51 | 195 | 39 |
30 Jun 20 | 228 | -65 | 191 | 44 |
31 Mar 20 | 230 | -55 | 190 | 39 |
31 Dec 19 | 215 | -55 | 180 | 37 |
30 Sep 19 | 197 | -54 | 163 | 35 |
30 Jun 19 | 181 | -45 | 150 | 27 |
31 Mar 19 | 165 | -48 | 143 | 24 |
31 Dec 18 | 147 | -50 | 133 | 21 |
30 Sep 18 | 134 | -45 | 123 | 18 |
30 Jun 18 | 120 | -42 | 111 | 17 |
31 Mar 18 | 108 | -35 | 96 | 15 |
31 Dec 17 | 99 | -30 | 85 | 13 |
30 Sep 17 | 89 | -25 | 73 | 11 |
30 Jun 17 | 81 | -22 | 65 | 9 |
31 Mar 17 | 73 | -20 | 57 | 8 |
31 Dec 16 | 64 | -21 | 52 | 7 |
30 Sep 16 | 56 | -22 | 48 | 7 |
30 Jun 16 | 49 | -24 | 45 | 7 |
31 Mar 16 | 41 | -24 | 40 | 6 |
31 Dec 15 | 36 | -23 | 37 | 6 |
30 Sep 15 | 32 | -19 | 31 | 6 |
31 Dec 14 | 22 | -16 | 20 | 6 |
31 Dec 13 | 15 | -14 | 14 | 4 |
Quality Earnings: IRTC is currently unprofitable.
Growing Profit Margin: IRTC is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IRTC is unprofitable, and losses have increased over the past 5 years at a rate of 20.7% per year.
Accelerating Growth: Unable to compare IRTC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IRTC is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.9%).
Return on Equity
High ROE: IRTC has a negative Return on Equity (-209.93%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 02:46 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
iRhythm Technologies, Inc. is covered by 21 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Michael Polark | Baird |
David Rescott | Baird |
Joanne Wuensch | BMO Capital Markets Equity Research |